D. Hersby

发表

SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients

M. Nielsen, S. Hadrup, S. Saini, 2020, bioRxiv.

T-cell ALL in ataxia telangiectasia cured with only 7 weeks of anti-leukemic therapy.

K. Schmiegelow, D. Hersby, A. Sehested, 2015, Journal of pediatric hematology/oncology.

High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms.

F. Girodon, H. Hasselbalch, D. Hersby, 2015, European journal of internal medicine.

Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

R. Agius, J. Lundgren, C. MacPherson, 2022, Communications Medicine.

A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera

V. Jooste, F. Girodon, P. Johansson, 2017, British journal of haematology.

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients

M. Nielsen, S. Hadrup, S. Saini, 2021, Science Immunology.

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients

L. Buonaguro, S. Hadrup, S. Saini, 2022, bioRxiv.

COVID-19-associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of SARS-CoV-2 diagnostics

D. Hersby, T. H. Nielsen, A. Gang, 2020, Annals of Oncology.

Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era

D. Hersby, T. Larsen, D. Hansen, 2023, Annals of Hematology.

Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma

D. Hersby, E. Høgdall, L. Pedersen, 2023, Leukemia & lymphoma.

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

L. Pagano, F. Farina, A. Cingolani, 2023, Journal of Hematology & Oncology.

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

L. Pagano, Gina Varricchio, F. Farina, 2023, eClinicalMedicine.

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

A. Barać, Gina Varricchio, G. Nadali, 2024, EClinicalMedicine.

Sexual health and testosterone concentration in male lymphoma survivors: A systematic review

D. Hersby, Signe Micas Pedersen, Claus Larsen Feltoft, 2024, Heliyon.